NPs Basic Information

Name
Verruculogen
Molecular Formula C27H33N3O7
IUPAC Name*
(9R,14S,17S,23R,24S)-23,24-dihydroxy-5-methoxy-12,12-dimethyl-9-(2-methylprop-1-enyl)-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.02,7.08,25.015,23.017,21]pentacosa-1(25),2(7),3,5-tetraene-16,22-dione
SMILES
CC(=C[C@@H]1N2C3=C(C=CC(=C3)OC)C4=C2[C@H](CC(OO1)(C)C)N5C(=O)[C@@H]6CCCN6C(=O)[C@@]5([C@H]4O)O)C
InChI
InChI=1S/C27H33N3O7/c1-14(2)11-20-29-18-12-15(35-5)8-9-16(18)21-22(29)19(13-26(3,4)37-36-20)30-24(32)17-7-6-10-28(17)25(33)27(30,34)23(21)31/h8-9,11-12,17,19-20,23,31,34H,6-7,10,13H2,1-5H3/t17-,19-,20+,23-,27+/m0/s1
InChIKey
LRXYHMMJJCTUMY-GWXUGYLUSA-N
Synonyms
verruculogen; 12771-72-1; TR 1 toxin; TR 1; CHEBI:72765; (5R,10S,10aR,14aS,15bS)-10,10a-dihydroxy-6-methoxy-2,2-dimethyl-5-(2-methylprop-1-en-1-yl)-1,10,10a,14,14a,15b-hexahydro-12H-3,4-dioxa-5a,11a,15a-triazacycloocta[1,2,3-lm]indeno[5,6-b]fluorene-11,15(2H,13H)-dione; (9R,14S,17S,23R,24S)-23,24-dihydroxy-5-methoxy-12,12-dimethyl-9-(2-methylprop-1-enyl)-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.02,7.08,25.015,23.017,21]pentacosa-1(25),2(7),3,5-tetraene-16,22-dione; 4-Methyl-4-(2-(4-nitro-N-phenylbenzamido)ethyl)morpholin-4-ium bromide; Verrculogen; Verruculogen, powder; CHEMBL551369; DTXSID30894030; TR1; MFCD00079645; ZINC85564414; AKOS030213151; 5H,12H-3,4-Dioxa-5a,11a,15a-triazacyclooct[lm]indeno[5,6-b]fluorene-11,15(2H,13H)-dione,1,10,10a,14,14a,15b-hexahydro-10,10a-dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methyl-1-propenyl)-, (5R,10S,10aR,14aS,15bS)-; C20045; J-005532; (5R,10S,10aR,14aS,15bS)-10,10a-Dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methylprop-1-en-1-yl)-1,10,10a,12,13,14,14a,15b-octahydro-3,4-dioxa-5a,11a,15a-triazacycloocta[lm]indeno[5,6-b]fluorene-11,15(2H,5H)-dione; (5R-(5alpha,10 alpha,10aalpha,14aalpha,15balpha))-1,10,10a,14,14a,15b-Hexahydro-10,10a-dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methyl-1-propenyl)-5H,12H-3,4-dioxa-5a,11a,15a-triaza cyclooct (1m) indeno (5,6-b)fluorene-11,15(2H,13H)-dione; 10,10a-dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methylprop-1-en-1-yl)- 1,10,10a,14,14a,15b-hexahydro-5H,12H-3,4-dioxa-5a,11a,15a- triazacyclooct[lm]indeno[5,6-b]fluorene-11,15(2H,13H)-dione; 5H,12H-3,4-Dioxa-5a,11a,15a-triazacyclooct(lm)indeno(5,6-b)fluorene-11,15(2H,13H)-dione, 1,10,10a,14,14a,15b-hexahydro-10,10a-dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methyl-1-propenyl)-, (5R,10S,10aR,14aS,15bS)-; 5H,12H-3,4-Dioxa-5a,11a,15a-triazacyclooct(lm)indeno(5,6-b)fluorene-11,15(2H,13H)-dione, 1,10,10a,14,14a,15b-hexahydro-10,10a-dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methyl-1-propenyl)-,(5R-(5-alpha,10-alpha,10a-alpha,14a-alpha-15b-alpha))-; 8H5
CAS 12771-72-1
PubChem CID 13887805
ChEMBL ID CHEMBL551369
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Indoles and derivatives
        • Subclass: Pyridoindoles
          • Direct Parent: Beta carbolines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 511.6 ALogp: 1.8
HBD: 2 HBA: 7
Rotatable Bonds: 2 Lipinski's rule of five: Rejected
Polar Surface Area: 114.0 Aromatic Rings: 6
Heavy Atoms: 37 QED Weighted: 0.467

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.874 MDCK Permeability: 0.00001460
Pgp-inhibitor: 0.995 Pgp-substrate: 0.534
Human Intestinal Absorption (HIA): 0.063 20% Bioavailability (F20%): 0.47
30% Bioavailability (F30%): 0.904

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.255 Plasma Protein Binding (PPB): 83.16%
Volume Distribution (VD): 1.43 Fu: 9.42%

ADMET: Metabolism

CYP1A2-inhibitor: 0.016 CYP1A2-substrate: 0.117
CYP2C19-inhibitor: 0.548 CYP2C19-substrate: 0.912
CYP2C9-inhibitor: 0.689 CYP2C9-substrate: 0.796
CYP2D6-inhibitor: 0.012 CYP2D6-substrate: 0.15
CYP3A4-inhibitor: 0.472 CYP3A4-substrate: 0.936

ADMET: Excretion

Clearance (CL): 8.571 Half-life (T1/2): 0.271

ADMET: Toxicity

hERG Blockers: 0.02 Human Hepatotoxicity (H-HT): 0.989
Drug-inuced Liver Injury (DILI): 0.989 AMES Toxicity: 0.039
Rat Oral Acute Toxicity: 0.082 Maximum Recommended Daily Dose: 0.997
Skin Sensitization: 0.192 Carcinogencity: 0.459
Eye Corrosion: 0.003 Eye Irritation: 0.005
Respiratory Toxicity: 0.802
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000842 0.787 D06YFA 0.277
ENC000837 0.636 D02IQY 0.263
ENC001958 0.595 D01TSI 0.257
ENC003264 0.595 D0V3ZA 0.250
ENC003265 0.528 D0SP3D 0.250
ENC005479 0.508 D09NNH 0.243
ENC003281 0.500 D06HBQ 0.242
ENC003013 0.496 D01XWG 0.235
ENC002064 0.475 D0Q0PR 0.235
ENC002846 0.450 D0V6OA 0.232
*Note: the compound similarity was calculated by RDKIT.